TrialWorld journal of urology2022

Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial.

Félix Guerrero-Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.